A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

NCT07290855 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Bradykinin-mediated Angioedema
Hereditary Angioedema (HAE)

Interventions

DRUG: Icatibant Injection (Icanticure®)

Sponsor

Nang Kuang Pharmaceutical Co., Ltd.